Clinical Trial Update: norUrsodeoxycholic Acid vs Placebo in PSC [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating norUrsodeoxycholic Acid (norUDCA) vs placebo for Primary Sclerosing Cholangitis. The study is currently ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• norUrsodeoxycholic Acid (norursodeoxycholic acid)

Snippet

Sponsor: Dr. Falk Pharma GmbH | Conditions: Primary Sclerosing Cholangitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING